Determination of prostate adenoma weight reduction due to vaporisation process occurring during transurethral resection of the prostate
- PMID: 25337165
- PMCID: PMC4198647
- DOI: 10.5114/wiitm.2014.44141
Determination of prostate adenoma weight reduction due to vaporisation process occurring during transurethral resection of the prostate
Abstract
Introduction: Transurethral resection of the prostate (TURP) is regarded as the gold standard surgical treatment for benign prostatic hyperplasia (BPH). The completeness of TURP may be assessed indirectly by estimation of the weight of glandular tissue removed. This parameter is often lower than expected. Tissue vaporisation in the course of TURP could be a contributory cause.
Aim: To quantitatively evaluate tissue vaporisation occurring in the course of transurethral resection of the prostate and electrovaporisation of the prostate (EVAP) performed under experimental conditions.
Material and methods: The study was performed on 26 prostate glands removed during retropubic prostatectomy. Immediately following surgery all adenomas were halved and TURP or EVAP were carried out on both halves of each gland for period of 5 min. The amount of prostate tissue which vaporised during EVAP and TURP were calculated.
Results: The mean weight (± standard deviation) of the adenoma lost due to resection and vaporisation in the TURP group was 10.00 ±2.92 g and 4.26 ±1.59 g, respectively. The latter accounted for 30.10 ±7.71% of total prostate weight reduction. The mean prostate weight lost in the course of EVAP was 5.03 ±1.58 g.
Conclusions: The vaporisation significantly contributes to the prostate tissue loss occurring during transurethral resection of the prostate.
Keywords: adenoma; transurethral resection of the prostate; vaporisation.
Figures



Similar articles
-
Electrocoagulation Accounts for a Significant Portion of Discrepancy Between Preoperative Ultrasonography Prostate Size Estimation and Resected Tissue Weight.J Endourol. 2020 Jun;34(6):671-675. doi: 10.1089/end.2020.0037. Epub 2020 Apr 22. J Endourol. 2020. PMID: 32204614
-
[Comparison of prostatic electro-vaporization and transurethral resection in the treatment of benign prostatic hypertrophy].Ann Chir. 1997;51(8):884-6. Ann Chir. 1997. PMID: 9734098 French.
-
Measurement of residual adenoma after transurethral resection of the prostate by transurethral enucleation technique.Urol Int. 2005;74(2):102-7. doi: 10.1159/000083278. Urol Int. 2005. PMID: 15756059
-
Randomised evaluation of alternative electrosurgical modalities to treat bladder outflow obstruction in men with benign prostatic hyperplasia.Health Technol Assess. 2005 Feb;9(4):iii-iv, 1-30. doi: 10.3310/hta9040. Health Technol Assess. 2005. PMID: 15698525 Review.
-
A review of the recent evidence (2006-2008) for 532-nm photoselective laser vaporisation and holmium laser enucleation of the prostate.Eur Urol. 2009 Jun;55(6):1345-57. doi: 10.1016/j.eururo.2009.03.070. Epub 2009 Apr 3. Eur Urol. 2009. PMID: 19361906 Review.
References
-
- Oelke M, Bachmann A, Descazeaud A, et al. EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction. Eur Urol. 2013;64:118–40. - PubMed
-
- Mencaglia L, Carri G, Prasciolu C, et al. Source feasibility and complications in bipolar resectoscopy: preliminary experience. Minim Invasive Ther Allied Technol. 2013;22:50–5. - PubMed
-
- Michielsen DP, Coomans D, Peeters I, Braeckman JG. Conventional monopolar resection or bipolar resection in saline for the management of large (> 60 g) benign prostatic hyperplasia: an evaluation of morbidity. Minim Invasive Ther Allied Technol. 2010;19:207–13. - PubMed
-
- Ingimarsson JP, Isaksson HJ, Sigbjarnarson HP, et al. Increased population use of medications for male lower urinary tract symptoms/benign prostatic hyperplasia correlates with changes in indications for transurethral resection of the prostate. Scand J Urol. 2014;48:73–8. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources